Testing a wearable heart monitor
Part of Heart & circulation clinical trials.
This study is testing a new wearable device that tracks your heart's electrical activity. It is designed to see if it works as well as a standard ECG machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You need to be able to speak and understand English.
- You must not have a serious heart condition that could interfere with the device.
- You cannot be on a ventilator or life support.
- You must not have any other serious or life-threatening illness.
- You cannot be pregnant or breastfeeding.
- You must be able to tolerate wearing the device and a standard ECG.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study tests if a wearable ECG device can help detect atrial fibrillation (AF), an irregular heartbeat that can raise stroke risk, in people at higher risk for stroke. You would wear the device for a while to see if it picks up signs of AF that need treatment.
This trial tests a wearable heart monitor (ECG) to see how well it works and stays accurate for patients in the hospital. It may help you if you need continuous heart monitoring without being tethered to a traditional machine.
This study tests whether a small adhesive heart-monitoring patch can detect atrial fibrillation (an irregular heartbeat) in people 60 and older who have never been diagnosed with it. Finding atrial fibrillation early may help prevent serious complications like stroke.
This study compares different computer “analysis methods” that look at real-time heart recordings from people with atrial fibrillation. It may help improve how atrial fibrillation is evaluated during/after an ablation procedure.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.